Literature DB >> 25813550

Development and validation of a clinical prediction rule for candidemia in hospitalized patients with severe sepsis and septic shock.

Cristina Vazquez Guillamet1, Rodrigo Vazquez2, Scott T Micek3, Oleg Ursu4, Marin Kollef5.   

Abstract

OBJECTIVE: To develop and internally validate a prediction rule for the presence of candidemia in patients with severe sepsis and septic shock (candidemia rule) that will fill the gap left by previous rules. To compare the accuracy of the available Candida prediction models.
DESIGN: Retrospective cohort study.
SETTING: Barnes-Jewish Hospital, St. Louis, Missouri. PATIENTS/
SUBJECTS: Two thousand five hundred ninety-seven consecutive patients with a positive blood culture and severe sepsis or septic shock.
INTERVENTIONS: Logistic regression and a bootstrap resampling procedure were employed for model development and internal validation.
MEASUREMENTS AND MAIN RESULTS: Two hundred sixty-six (10.2%) had blood cultures positive for Candida spp. Mortality was significantly higher in patients with candidemia than in patients with bacteremia (47.0% versus 28.4%; P<.001). Administration of total parenteral nutrition, prior antibiotic exposure, transfer from an outside hospital or admission from a nursing home, mechanical ventilation and presence of a central vein catheter were independent predictors of candidemia while the lung as a source for infection was protective. The prediction rule had an area under the receiver operating characteristic curve of 0.798 (95% CI 0.77-0.82). Internal validation using bootstrapping technique with 1000 repetitions produced a similar area under the receiver operating characteristic curve of 0.797 (bias, -0.037; root mean square error 0.039). Our prediction rule outperformed previous rules with a better calibration slope of 0.96 and Brier score of 0.08.
CONCLUSIONS: We developed and internally validated a prediction rule for candidemia in hospitalized patients with severe sepsis and septic shock that outperformed previous prediction rules. Our study suggests that locally derived prediction models may be superior by accounting for local case mix and risk factor distribution.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Candida; Mortality; Outcomes; Prediction; Septic shock

Mesh:

Year:  2015        PMID: 25813550     DOI: 10.1016/j.jcrc.2015.03.010

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  9 in total

1.  Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards.

Authors:  Francesco Sbrana; Emanuela Sozio; Matteo Bassetti; Andrea Ripoli; Filippo Pieralli; Anna Maria Azzini; Alessandro Morettini; Carlo Nozzoli; Maria Merelli; Sebastiano Rizzardo; Giacomo Bertolino; Davide Carrara; Claudio Scarparo; Ercole Concia; Francesco Menichetti; Carlo Tascini
Journal:  Intern Emerg Med       Date:  2018-01-10       Impact factor: 3.397

2.  Evaluating predictors of invasive candidiasis in patients with and without candidemia on micafungin.

Authors:  Amy Carr; Peter Colley; Mezgebe Berhe; Hoa L Nguyen
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-01-02

3.  ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.

Authors:  Ignacio Martin-Loeches; Massimo Antonelli; Manuel Cuenca-Estrella; George Dimopoulos; Sharon Einav; Jan J De Waele; Jose Garnacho-Montero; Souha S Kanj; Flavia R Machado; Philippe Montravers; Yasser Sakr; Maurizio Sanguinetti; Jean-Francois Timsit; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2019-03-25       Impact factor: 17.440

4.  Machine Learning in Infectious Disease for Risk Factor Identification and Hypothesis Generation: Proof of Concept Using Invasive Candidiasis.

Authors:  Lisa M Mayer; Jeffrey R Strich; Sameer S Kadri; Michail S Lionakis; Nicholas G Evans; D Rebecca Prevots; Emily E Ricotta
Journal:  Open Forum Infect Dis       Date:  2022-08-03       Impact factor: 4.423

5.  Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case-Control Study.

Authors:  Daniele Roberto Giacobbe; Antonio Salsano; Filippo Del Puente; Ambra Miette; Antonio Vena; Silvia Corcione; Michele Bartoletti; Alessandra Mularoni; Alberto Enrico Maraolo; Maddalena Peghin; Alessia Carnelutti; Angela Raffaella Losito; Francesca Raffaelli; Ivan Gentile; Beatrice Maccari; Stefano Frisone; Renato Pascale; Elisa Mikus; Alice Annalisa Medaglia; Elena Conoscenti; Davide Ricci; Tommaso Lupia; Marco Comaschi; Maddalena Giannella; Mario Tumbarello; Francesco Giuseppe De Rosa; Valerio Del Bono; Malgorzata Mikulska; Francesco Santini; Matteo Bassetti
Journal:  Open Forum Infect Dis       Date:  2020-06-19       Impact factor: 3.835

6.  Incidence and risk factors for COVID-19 associated candidemia (CAC) in ICU patients.

Authors:  Bircan Kayaaslan; Ayşe Kaya Kalem; Dilek Asilturk; Betul Kaplan; Gülen Dönertas; Imran Hasanoglu; Fatma Eser; Ruveyda Korkmazer; Zeynep Oktay; Isıl Ozkocak Turan; Deniz Erdem; Hesna Bektas; Rahmet Guner
Journal:  Mycoses       Date:  2022-03-10       Impact factor: 4.931

7.  Development and validation of COVID-19 associated candidemia score (CAC-Score) in ICU patients.

Authors:  Bircan Kayaaslan; Fatma Eser; Dilek Asilturk; Zeynep Oktay; Imran Hasanoglu; Ayşe Kaya Kalem; Gülen Dönertaş; Betul Kaplan; Isıl Ozkocak Turan; Deniz Erdem; Hesna Bektas; Rahmet Guner
Journal:  Mycoses       Date:  2022-09-22       Impact factor: 4.931

8.  Clinical predictive models of invasive Candida infection: A systematic literature review.

Authors:  Adriana M Rauseo; Abdullah Aljorayid; Margaret A Olsen; Lindsey Larson; Kim L Lipsey; William G Powderly; Andrej Spec
Journal:  Med Mycol       Date:  2021-11-03       Impact factor: 3.747

9.  Candidemia Risk Prediction (CanDETEC) Model for Patients With Malignancy: Model Development and Validation in a Single-Center Retrospective Study.

Authors:  Junsang Yoo; Si-Ho Kim; Sujeong Hur; Juhyung Ha; Kyungmin Huh; Won Chul Cha
Journal:  JMIR Med Inform       Date:  2021-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.